I fear that a big MedTech will not want to partner with RSH...

I fear that a big MedTech will not want to partner with RSH given the Board as it now stands (chairman and Prof). A company needs a serious board (people with serious credentials in the MedTech space) to be taken seriously and IMO Mario has the global connections to bring in a fresh and experienced board to move RSH to next phase. IMO he is the only one that can land the plane. Looking for a new CEO with as good of a resume takes time, and then being brought up to speed takes further time which will surely further delay the company's success. IMO we are too close to the goal post now to let this fail because of an incompetent board. i like to use analogies and at the moment I feel there is a serious cancer inside the company and just like any cancer it needs to be excised immediately for any chance of survival. We long suffering shareholders must unite to get rid of the cancer sooner rather than later. IMO